![Omar Khalil](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Omar Khalil
Directeur/Membre du Conseil chez Solu Therapeutics
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Kevin Lalande | M | 51 |
SHVMS, LLC
![]() SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | 18 ans |
Joe Almeida | M | 61 | 9 ans | |
Frank G. Haluska | M | 64 |
Kestrel Therapeutics, Inc.
![]() Kestrel Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kestrel Therapeutics, Inc. is a company that has two habitat restoration projects aimed at helping native animals that are at risk, specifically the American Kestrel and the Eastern Spadefoot Toad. The company is based in Wayland, MA. The company's mission is to conserve and care for forests, farms, and riverways of the Pioneer Valley while nurturing an enduring love of the land. The CEO of the company is Frank G. Haluska. | - |
Niranjan Y. Sardesai | M | 56 |
Geneos Therapeutics, Inc.
![]() Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | 7 ans |
Doug French | M | 70 |
SHVMS, LLC
![]() SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | 18 ans |
Brandon Turunen | M | - |
Solu Therapeutics
![]() Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | - |
GOAD FRED | M | 79 |
SHVMS, LLC
![]() SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | - |
Eric Epstein | M | - |
SHVMS, LLC
![]() SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | 5 ans |
Joann Peters | F | - |
Geneos Therapeutics, Inc.
![]() Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | 5 ans |
Dennis McWilliams | M | 53 |
SHVMS, LLC
![]() SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | 5 ans |
John Pribis | M | - |
Solu Therapeutics
![]() Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | - |
Reaz Rasul | M | - | 7 ans | |
Joe Cunningham | M | - |
SHVMS, LLC
![]() SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | 18 ans |
Philip Vickers | M | 64 |
Solu Therapeutics
![]() Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | - |
Satoshi Konagai | M | - |
Solu Therapeutics
![]() Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | - |
Denis Patrick | M | - |
Kestrel Therapeutics, Inc.
![]() Kestrel Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kestrel Therapeutics, Inc. is a company that has two habitat restoration projects aimed at helping native animals that are at risk, specifically the American Kestrel and the Eastern Spadefoot Toad. The company is based in Wayland, MA. The company's mission is to conserve and care for forests, farms, and riverways of the Pioneer Valley while nurturing an enduring love of the land. The CEO of the company is Frank G. Haluska. | - |
Christopher Smith | M | - |
MycRx
![]() MycRx Miscellaneous Commercial ServicesCommercial Services MycRx is an Australian company that focuses on improving the lives of people with cancer through direct myc inhibitors. The company's main area of expertise is the science of myc inhibition as a treatment for cancer. | - |
Ellen K. Bradford | F | - | 9 ans | |
Andrew Phillips | M | - |
Kestrel Therapeutics, Inc.
![]() Kestrel Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kestrel Therapeutics, Inc. is a company that has two habitat restoration projects aimed at helping native animals that are at risk, specifically the American Kestrel and the Eastern Spadefoot Toad. The company is based in Wayland, MA. The company's mission is to conserve and care for forests, farms, and riverways of the Pioneer Valley while nurturing an enduring love of the land. The CEO of the company is Frank G. Haluska. | - |
Stephen Thompson | M | - |
MycRx
![]() MycRx Miscellaneous Commercial ServicesCommercial Services MycRx is an Australian company that focuses on improving the lives of people with cancer through direct myc inhibitors. The company's main area of expertise is the science of myc inhibition as a treatment for cancer. | - |
Peter Smith | M | - |
MycRx
![]() MycRx Miscellaneous Commercial ServicesCommercial Services MycRx is an Australian company that focuses on improving the lives of people with cancer through direct myc inhibitors. The company's main area of expertise is the science of myc inhibition as a treatment for cancer. | - |
Alison Thistlethwaite | M | - |
MycRx
![]() MycRx Miscellaneous Commercial ServicesCommercial Services MycRx is an Australian company that focuses on improving the lives of people with cancer through direct myc inhibitors. The company's main area of expertise is the science of myc inhibition as a treatment for cancer. | - |
Ashley Seehusen | M | - |
SHVMS, LLC
![]() SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | - |
Katie McInnis | F | - |
SHVMS, LLC
![]() SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | 2 ans |
Blakeley McCracken | M | - |
SHVMS, LLC
![]() SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | 8 ans |
Sangwoo Lee | M | 52 |
Geneos Therapeutics, Inc.
![]() Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | 4 ans |
James Eadie | M | - |
SHVMS, LLC
![]() SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | 14 ans |
Ted Ingemar Jakob Fjällman | M | 46 |
Geneos Therapeutics, Inc.
![]() Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | 2 ans |
Laurent Humeau | M | 57 |
Geneos Therapeutics, Inc.
![]() Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | 2 ans |
Peter Hutt | M | 89 |
Solu Therapeutics
![]() Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | - |
Louis C. Bock | M | 59 |
SHVMS, LLC
![]() SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | 10 ans |
John Hamer | M | 66 |
Solu Therapeutics
![]() Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | - |
Christoph Westphal | M | 56 |
Solu Therapeutics
![]() Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | - |
A. Michael Hoffman | M | - |
SHVMS, LLC
![]() SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | - |
Julie Cherrington | M | 66 |
MycRx
![]() MycRx Miscellaneous Commercial ServicesCommercial Services MycRx is an Australian company that focuses on improving the lives of people with cancer through direct myc inhibitors. The company's main area of expertise is the science of myc inhibition as a treatment for cancer. | 2 ans |
Samuel Broder | M | 79 |
Geneos Therapeutics, Inc.
![]() Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | - |
William Cohn | M | 64 |
SHVMS, LLC
![]() SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | 14 ans |
Andrew Phillips | M | 53 |
Kestrel Therapeutics, Inc.
![]() Kestrel Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kestrel Therapeutics, Inc. is a company that has two habitat restoration projects aimed at helping native animals that are at risk, specifically the American Kestrel and the Eastern Spadefoot Toad. The company is based in Wayland, MA. The company's mission is to conserve and care for forests, farms, and riverways of the Pioneer Valley while nurturing an enduring love of the land. The CEO of the company is Frank G. Haluska. | - |
Stacey T. Eisen | F | - | 8 ans | |
Peter Smith | M | 61 |
MycRx
![]() MycRx Miscellaneous Commercial ServicesCommercial Services MycRx is an Australian company that focuses on improving the lives of people with cancer through direct myc inhibitors. The company's main area of expertise is the science of myc inhibition as a treatment for cancer. | - |
Thomas Krummel | M | 72 |
SHVMS, LLC
![]() SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | 3 ans |
Casey Cunningham | M | - |
SHVMS, LLC
![]() SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | 16 ans |
Jason Brandt | M | - |
SHVMS, LLC
![]() SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | 6 ans |
Shawn Tomasello | F | 65 |
Geneos Therapeutics, Inc.
![]() Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | - |
Sang-Woo Lee | M | - |
Geneos Therapeutics, Inc.
![]() Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | 3 ans |
Auriel August | F | - |
SHVMS, LLC
![]() SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | 1 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Robert Davis | M | 57 | 10 ans | |
Uma Chowdhry | M | 76 | 4 ans | |
Robert Hombach | M | 58 | 26 ans | |
Fang-Tyan Chen | M | 74 | 11 ans | |
Munib Ziaul Islam | M | 50 | 4 ans | |
Michael Mahoney | M | 59 | 8 ans | |
Blake E. Devitt | M | 77 | 10 ans | |
Wayne T. Hockmeyer | M | 79 | 8 ans | |
Gail Fosler | F | 76 | 14 ans | |
Caroline D. Karp | F | 50 | 2 ans | |
Eric Foster | M | 52 | 9 ans | |
Robert J. Weiland | M | 64 | 7 ans | |
Scott Pleau | M | - | - | |
Irina P. Konstantinovsky | F | 54 | 5 ans | |
Laura Angelini | F | 60 | 5 ans | |
Meredith S. Manning | F | - | 2 ans | |
Hartmut Ehrlich | M | - | 7 ans | |
Richard Marritt | M | - | 15 ans | |
Jean-Luc Butel | M | 67 | 3 ans | |
Jacques Suzanne | F | 53 | - | |
Christopher Miskel | M | 49 | 4 ans | |
Royston Glasspool | M | 61 | 3 ans | |
Anila Lingamneni | F | 57 | 7 ans | |
Alfred Macdaniel | M | - |
SHVMS, LLC
![]() SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | 5 ans |
Kyle Wilks | M | 47 | 6 ans | |
Alicja Januszewicz | M | - | 1 ans | |
Andrew Frye | M | - | - | |
Caroline Larew | F | - | 1 ans | |
Parth Chakrabarti | M | - | 3 ans | |
Brent Rutland | M | - | 1 ans | |
Derek Mazur | M | - |
SHVMS, LLC
![]() SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | 6 ans |
Camille Farhat | M | 55 | 5 ans | |
Francois Lebel | M | 72 | 1 ans | |
Brad Wolfe | M | 64 |
SHVMS, LLC
![]() SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | 2 ans |
Sumant Ramachandra | M | 55 | 4 ans | |
Sebastian J. Bufalino | M | 63 | 16 ans | |
Norbert Riedel | M | 66 | 15 ans | |
Blaine F. Wesner | M | - |
SHVMS, LLC
![]() SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | - |
David Roman | M | 42 | 5 ans | |
Paul Martin | M | 66 | 9 ans | |
Gerald Lema | M | 63 | 10 ans | |
Sven Anders Ullman | M | 68 | 1 ans | |
Ludwig Hantson | M | 61 | 5 ans | |
Marcus Schabacker | M | 60 | - | |
Wilber Boren | M | 51 | - | |
Jim Graham | M | - |
SHVMS, LLC
![]() SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | - |
Joel Lang | M | - |
SHVMS, LLC
![]() SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | - |
Jenny Murphy | F | - |
SHVMS, LLC
![]() SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | - |
Alfred Macdaniel | M | - |
SHVMS, LLC
![]() SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | - |
Stuart Paul | M | 64 | 2 ans | |
Lina Karlsson | M | 51 | 5 ans | |
Ellen K. McIntosh | F | - | - | |
Douglas Losordo | M | 65 | 2 ans | |
Kimberly Ann Davis | F | 56 |
Kaleo, Inc.
![]() Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA. | 6 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 94 | 94,00% |
Australie | 6 | 6,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Omar Khalil
- Réseau Personnel